Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Consolidated Financial Performance and Segment Highlights
CAH logo

Cardinal Health Revenue Jumps 22% to $64B on Specialty Pharma Boom

CAH10-QFiling Date: 10/30/2025
Cardinal Health Inc
Description

What this story covers

Cardinal Health's Q1 FY2026 10-Q shows 22% revenue growth to $64B, driven by specialty pharma and acquisitions. Non-GAAP earnings rose 37%. Liquidity is strong at $4.6B, supporting buybacks amid opioid settlements and risks.

Story snapshot

CompanyCardinal Health Inc
TickerCAH
VariantStandard detailed
Duration12:32
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0000721371-25-000130

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in